Cargando…

Acute pancreatitis associated with indigo naturalis in pediatric severe Crohn’s disease

The incidence of inflammatory bowel disease (IBD) is rapidly increasing worldwide. Indigo naturalis is known to have an antiinflammatory effect. Indigo naturalis has been traditionally used in the treatment of IBD in China and Japan. Currently, it is used as a primary or adjunctive drug in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyeon-A, Suh, Hyo-rim, Kang, Ben, Choe, Byung-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361016/ https://www.ncbi.nlm.nih.gov/pubmed/30317857 http://dx.doi.org/10.5217/ir.2018.00104

Ejemplares similares

Treatment-refractory ulcerative colitis responsive to indigo naturalis
por: Saiki, Julie P, et al.
Publicado: (2021)

Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report
por: Cho, Byungha, et al.
Publicado: (2020)

Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia
por: Lou, Yinjun, et al.
Publicado: (2021)

Beneficial effect of Indigo Naturalis on acute lung injury induced by influenza A virus
por: Tu, Peng, et al.
Publicado: (2020)

Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series
por: Urushikubo, Jun, et al.
Publicado: (2019)

An In Vitro Study of the Antimicrobial Effects of Indigo Naturalis Prepared from Strobilanthes formosanus Moore
por: Chiang, Yin-Ru, et al.
Publicado: (2013)

Benefits of topical indigo naturalis nanofibrous patch on psoriatic skin: A transdermal strategy for botanicals
por: Wang, Pengyu, et al.
Publicado: (2023)

Oral Realgar-Indigo Naturalis Formula Treatment for Acute Promyelocytic Leukemia in Children: A Randomized, Control Clinical Trial
por: Luo, Senlin, et al.
Publicado: (2022)

Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis
por: Cheng, Hui-Man, et al.
Publicado: (2017)

Indigo Naturalis Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating the Intestinal Microbiota Community
por: Liang, Yan-Ni, et al.
Publicado: (2019)

Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota
por: Sun, Zhongmei, et al.
Publicado: (2020)

Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study
por: Yang, Ming‐Hua, et al.
Publicado: (2018)

Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis
por: Wang, Yunliang, et al.
Publicado: (2017)

A Comprehensive Review of the Chemistry, Pharmacokinetics, Pharmacology, Clinical Applications, Adverse Events, and Quality Control of Indigo Naturalis
por: Sun, Quan, et al.
Publicado: (2021)

Efficacy and Safety of Indigo Naturalis in Combination with Narrow-Band Ultraviolet B for Treatment of Pityriasis Rosea: A Meta-Analysis
por: Wang, L., et al.
Publicado: (2018)

Mechanisms of indigo naturalis on treating ulcerative colitis explored by GEO gene chips combined with network pharmacology and molecular docking
por: Gu, Sizhen, et al.
Publicado: (2020)

Indigo Naturalis Suppresses Colonic Oxidative Stress and Th1/Th17 Responses of DSS-Induced Colitis in Mice
por: Xiao, Hai-tao, et al.
Publicado: (2019)

One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
por: Matsuno, Yuichi, et al.
Publicado: (2022)

Traditional mineral medicine realgar and Realgar-Indigo naturalis formula potentially exerted therapeutic effects by altering the gut microbiota
por: Luo, Lu, et al.
Publicado: (2023)

Clinical Study on Prospective Efficacy of All-Trans Acid, Realgar-Indigo Naturalis Formula Combined with Chemotherapy as Maintenance Treatment of Acute Promyelocytic Leukemia
por: Xiang-Xin, Li, et al.
Publicado: (2014)

Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial
por: Uchiyama, Kan, et al.
Publicado: (2020)

From natural dye to herbal medicine: a systematic review of chemical constituents, pharmacological effects and clinical applications of indigo naturalis
por: Qi-yue, Yang, et al.
Publicado: (2020)

Influences of Realgar-Indigo naturalis, A Traditional Chinese Medicine Formula, on the Main CYP450 Activities in Rats Using a Cocktail Method
por: Xu, Huan-Hua, et al.
Publicado: (2017)

Characterization of anti-leukemia components from Indigo naturalis using comprehensive two-dimensional K562/cell membrane chromatography and in silico target identification
por: Wu, Xunxun, et al.
Publicado: (2016)

Comparison between Pediatric Crohn’s Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study
por: Park, Sowon, et al.
Publicado: (2022)

Saggio di naturali esperienze
por: Guadagni, Carlo Alfonso, et al.
Publicado: (1998)

Prevention of thiopurine-induced early leukopenia in a Korean pediatric patient with Crohn’s disease who turned out to possess homozygous mutations in NUDT15 R139C
por: Bae, Jaewoan, et al.
Publicado: (2020)

Corrigendum: Characterization of anti-leukemia components from Indigo naturalis using comprehensive two-dimensional K562/cell membrane chromatography and in silico target identification
por: Wu, Xunxun, et al.
Publicado: (2016)

Inhibitory Effect of Indigo Naturalis on Tumor Necrosis Factor-α-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Umbilical Vein Endothelial Cells
por: Chang, Hsin-Ning, et al.
Publicado: (2010)

Absorption Characteristics of Combination Medication of Realgar and Indigo Naturalis: In Vitro Transport across MDCK-MDR1 Cells and In Vivo Pharmacokinetics in Mice after Oral Administration
por: Zhang, Miao, et al.
Publicado: (2018)

Exploring the Mechanism of Indigo Naturalis in the Treatment of Ulcerative Colitis Based on TLR4/MyD88/NF-κB Signaling Pathway and Gut Microbiota
por: Yang, Qi-yue, et al.
Publicado: (2021)

Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial
por: Zhang, Xinxin, et al.
Publicado: (2020)

Indigo-Uria
Publicado: (1907)

Rapid and Integrated Quality Assessment of Organic-Inorganic Composite Herbs by FTIR Spectroscopy—Global Chemical Fingerprints Identification and Multiple Marker Components Quantification of Indigo Naturalis (Qing Dai)
por: Pan, Meng, et al.
Publicado: (2018)

Pediatric Crohn’s disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature
por: Kim, Eun Sil, et al.
Publicado: (2021)

Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn’s Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents
por: Lee, Yoo Min, et al.
Publicado: (2022)

Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
por: Choi, Sujin, et al.
Publicado: (2021)

Change in the treatment strategy for pediatric Crohn's disease
por: Kim, Mi Jin, et al.
Publicado: (2010)

Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target
por: Kang, Ben, et al.
Publicado: (2018)

Ellington indigos
por: Ellington, Duke, 1899-1974
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_7nmcqi6hmiohvgvqhi04hdnjvj